Hall Laurie J Trustee trimmed its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,149 shares of the medical equipment provider’s stock after selling 100 shares during the period. Hall Laurie J Trustee’s holdings in Zimmer Biomet Holdings were worth $276,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of ZBH. BlackRock Inc. lifted its holdings in Zimmer Biomet Holdings by 4,042.4% during the first quarter. BlackRock Inc. now owns 16,740,383 shares of the medical equipment provider’s stock valued at $2,044,168,000 after purchasing an additional 16,336,262 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Zimmer Biomet Holdings by 92.7% during the second quarter. JPMorgan Chase & Co. now owns 3,279,951 shares of the medical equipment provider’s stock valued at $421,146,000 after purchasing an additional 1,577,874 shares in the last quarter. Harbour Capital Advisors LLC lifted its holdings in Zimmer Biomet Holdings by 13,131.3% during the second quarter. Harbour Capital Advisors LLC now owns 1,302,618 shares of the medical equipment provider’s stock valued at $10,145,000 after purchasing an additional 1,292,773 shares in the last quarter. Koch Industries Inc. lifted its holdings in Zimmer Biomet Holdings by 49,697.3% during the second quarter. Koch Industries Inc. now owns 1,040,764 shares of the medical equipment provider’s stock valued at $1,033,000 after purchasing an additional 1,038,674 shares in the last quarter. Finally, Glenview Capital Management LLC purchased a new position in Zimmer Biomet Holdings during the first quarter valued at $94,197,000. 85.36% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Holdings Cut by Hall Laurie J Trustee” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/10/15/zimmer-biomet-holdings-inc-zbh-holdings-cut-by-hall-laurie-j-trustee.html.

ZBH has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 price objective on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Morgan Stanley increased their price objective on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, July 17th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $125.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Zimmer Biomet Holdings has a consensus rating of “Hold” and an average price target of $136.55.

In other news, VP Tony W. Collins sold 16,986 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.07% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down 0.77% during midday trading on Friday, hitting $119.70. 798,696 shares of the company’s stock were exchanged. The firm has a market cap of $24.20 billion, a PE ratio of 34.09 and a beta of 1.19. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.49. The stock’s 50-day moving average price is $116.07 and its 200 day moving average price is $120.38.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company’s revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.02 earnings per share. Equities research analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.23 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. The ex-dividend date is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.80%. Zimmer Biomet Holdings’s payout ratio is currently 27.59%.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.